Guangzhou Innogen Pharmaceutical Group

New Business

Why Hong Kong’s small stockbrokers are a dying breed despite a hot market

Close to 200 stockbrokers have closed their doors in Hong Kong since 2020, and industry players expect more to throw…

Read More »
New Business

Hong Kong exchange’s confidential filing option lures tech listing hopefuls, law firm says

Nearly half of the biotech and technology start-ups seeking initial public offerings (IPOs) in Hong Kong are opting for confidential…

Read More »
New Business

Innogen’s shares almost quadruple in Hong Kong debut amid demand for anti-obesity drugs

Shares of Guangzhou Innogen Pharmaceutical Group soared on their Hong Kong debut, buoyed by strong investor appetite for China’s pharmaceuticals…

Read More »
New Business

Hong Kong stocks sink as mainland China economic data, earnings reports trigger sell-off

Hong Kong stocks posted the first back-to-back decline in two weeks on Friday after China’s July economic data fell short…

Read More »
Back to top button